Colistin Plus Carbapenem versus Colistin Monotherapy in the Treatment of Carbapenem-Resistant Acinetobacter baumannii Pneumonia.

HyeJin ShiJin Seo Lee So Yeon Park Yousang Ko Joong Sik Eom

Published in: Infection and drug resistance (2019)

Despite more severe conditions, compared with colistin monotherapy, colistin plus carbapenem combination therapy showed equivalent primary mortality outcome in treating CRAB pneumonia. Combination therapy was more effective in patients with APACHE II score ranging from 25 to 29 points.

Keyphrases

combination therapy
acinetobacter baumannii
multidrug resistant
drug resistant
pseudomonas aeruginosa
klebsiella pneumoniae
gram negative
cardiovascular events
cystic fibrosis
early onset
escherichia coli
risk factors
intensive care unit
randomized controlled trial
cardiovascular disease
type diabetes